FindTrial
Sign In

The efficacy and safety of trigeminal nerve block via pterygopalatine fossa for treatment of primary trigeminal neuralgia

The efficacy and safety of trigeminal nerve block via pterygopalatine fossa for treatment of primary trigeminal neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032565
Enrollment
Unknown
Registered
2020-05-02
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary trigeminal neuralgia

Interventions

The group of nerve block:Trigeminal nerve block via pterygopalatine fossa

Sponsors

Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
31 Years to 84 Years

Inclusion criteria

Inclusion criteria: 1. The patient of primary trigeminal neuralgia; 2. Patients who fail in conservative drug therapy; 3. ASA grade: I-II; 4. Patients sign the consent form and willing to participate in this trial.

Exclusion criteria

Exclusion criteria: 1. Patients with the infection of puncture site, abnormal blood coagulation or local anesthetic allergy; 2. Patients with nerve injury who have received interventional therapy before operation; 3. Patients with visual and hearing impairment or the difficulties of communication; 4. Patients use of opioids or other analgesics with long-term.

Design outcomes

Primary

MeasureTime frame
Score of Visual Analogue Scale;Score of the Pain Assessment Table of Barrow Neurological Institute;—

Secondary

MeasureTime frame
Score of Self-Rating Anxiety Scale;Score of Self-Rating Depression Scale;Score of the Table of Likert's Perioperative satisfaction;—

Countries

China

Contacts

Public ContactXiangbo Liu
941154844@qq.com+86 18283028876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026